Effects of minimally invasive surgery combined with metformin on inflammatory responses in rabbits with intracerebral hemorrhage

doi:10.12307/2022.360

Abstract

Abstract: BACKGROUND: Our preliminary results have shown that minimally invasive surgery combined with metformin can reduce secondary damage after cerebral hemorrhage and improve the prognosis. However the specific mechanism is still unclear.
OBJECTIVE: To observe the effect of minimally invasive surgery combined with metformin on the inflammatory responses of brain tissue around hematoma in a rabbit model of intracerebral hemorrhage, and to explore its specific mechanism.
METHODS: Forty-eight male New Zealand rabbits were randomly divided into sham operation group (sham group), intracerebral hemorrhage group (ICH group), minimally invasive surgery group (MIS group), and minimally invasive surgery combined with metformin treatment group (MIS+MET group). Animal models of intracerebral hemorrhage were established using Sawyer’s method in the latter three groups. Pseudohematoma removal surgery was performed in the ICH group, and minimal invasive surgery was performed in the MIS group and MIS+MET group 6 hours after successful modeling. Metformin (50 mg/kg) was administered by gavage to the rabbits in the MIS+MET group once a day for 3 continuous days, and the rabbits in the MIS and ICH groups were given the same amount of normal saline. Neurological deficit (Purdy) score was performed 3 days after treatment. The content of brain water and Evans blue were detected. The expression of tumor necrosis factor-α and interleukin-1β in serum was detected by ELISA. The expressions of Toll-like receptor 4, matrix metalloproteinase 9 and nuclear factor κB proteins in brain tissue were detected by immunohistochemistry and western blot. An ethical approval was obtained from the Experimental Animal Ethics Committee of Shandong Provincial Third Hospital (approval No. DWKYLL-2017001).
RESULTS AND CONCLUSION: Compared with the ICH group, Purdy score, brain water content and Evans blue content were significantly decreased in the MIS group and MIS+Met group (P < 0.05), the expression levels of tumor necrosis factor-α and interleukin-1β in serum were decreased (P < 0.05), and the expression of Toll-like receptor 4, matrix metalloproteinase 9 and nuclear factor κB proteins in brain tissue were significantly decreased (P < 0.05). The above indexes were decreased more obviously in the MIS+MET group. These findings indicate that minimally invasive surgery combined with metformin could reduce the inflammatory response and improve the neurological function of rabbits with intracerebral hemorrhage by inhibiting Toll-like receptor 4/nuclear factor κB signaling pathway.

Key words: minimally invasive surgery, metformin, intracerebral hemorrhage, inflammatory response, Toll-like receptor 4, nuclear factor κB

CLC Number:

Xu Lin, Qi Hongshun, Ge Rucun, Li Peipei, Zhen Lixiao, Feng Xiaoya. Effects of minimally invasive surgery combined with metformin on inflammatory responses in rabbits with intracerebral hemorrhage[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(11): 1741-1746.

Figures/Tables 6

References

[1] ISABEL CH, DAVID JS, DAVID JW. Intracerebral hemorrhage: an update ondiagnosis and treatment. Expert Rev Neurother. 2019;19:679-694.
[2] SCAGGIANTE J, ZHANG X, MOCCO J, et al. Minimally Invasive Surgery forIntracerebral Hemorrhage. Stroke. 2018;49(11):2612-2620.
[3] HANLEY DF, THOMPSON RE, MUSCHELLI J, et al. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15(12):1228-1237.
[4] TANG Y, YIN F, FU D, et al. Efficacy and safety of minimal invasive surgery treatment in hypertensive intracerebral hemorrhage: a systematic review and meta-analysis. BMC Neurol. 2018;18:136.
[5] DUCRUET AF, HICKMAN ZL, ZACHARIA BE, et al. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery. 2010;66(5):648-655.
[6] LIAN LF, XU F, TANG ZP, et al. Intraclot recombinant tissuetype plasminogen activator reduces perihematomal edema and mortality in patients with spontaneous intracerebral hemorrhage. J Huazhong Univ Sci Technolog Med Sci. 2014;34(2):165-171.
[7] FATEMI I, SAEED-ASKARI P, HAKIMIZADEH E, et al. Long-term metformin therapy improves neurobehavioral functions and antioxidative activity after cerebral ischemia/reperfusion injury in rats. Brain Res Bull. 2020; 163:65-71.
[8] TAO L, LI D, LIU H, et al. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-kappaB and MAPK signaling pathway. Brain Res Bull. 2018;140:154-161.
[9] QI B, HU L, ZHU L, et al. Metformin Attenuates Neurological Deficit after Intracerebral Hemorrhage by Inhibiting Apoptosis, Oxidative Stress and Neuroinflammation in Rats. Neurochem Res. 2017;42(10):2912-2920.
[10] 徐林,齐宏顺,李培培,等. 微创清除术联合二甲双胍对家兔脑出血病灶周围TNF-α、IL-1β和Iba-1的影响[J].神经损伤与功能重建, 2020,15(8):435-438.
[11] SAWYER CH, EVERETT JW, GREEN JD. The rabbit diencephalons in stereotaxic coordinate. J Comp Neyrol. 1954;102:801-824.
[12] PURDY PD, DEVOUS MD SR, BATJER HH, et al. Microfibrillar collagen model of canine cerebral infarction. Stroke. 1989;20(10):1361-1367.
[13] 王娜. 微创穿刺血肿引流术联合尿激酶治疗基底节区脑出血的效果[J]. 临床医学研究与实践,2020,5(29):67-68.
[14] 李少泉, 彭文龙, 张维, 等. 微创颅内血肿清除术联合术后尿激酶溶解治疗基底核区高血压脑出血的效果及对神经功能、预后的影响研究[J].解放军医药杂志 ,2020,32(11):89-93.
[15] 李飞, 高伟伟, 徐新, 等. 二甲双胍对脑出血模型小鼠血肿周围脑组织炎症反应的影响[J]. 天津医药,2017,45(5):485-488.
[16] KARIMIPOUR M, SHOJAEIZARGHANI S, MOHAJERMILANI M, et al. Pre-Treatment with Metformin in Comparison with Post-Treatment Reduces Cerebral Ischemia Reperfusion Induced Injuries in Rats. Bull Emerg Trauma. 2018;6(2):115-121.
[17] HOU X, SONG J, LI XN, et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun. 2010;396(2):199-205.
[18] SAISHO Y. Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr Metab Immune Disord Drug Targets. 2015; 15(3):196-205.
[19] ZHU XC, JIANG T, ZHANG QQ, et al. Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-kappa B-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia. Mol Neurobiol. 2015;52(1):375-385.
[20] ZHOU Q, LIN FF, LIU SM, et al. Influence of the total saponin fraction from Dioscorea nipponica Makino on TLR2/4-IL1R receptor singnal pathway in rats of gouty arthritis. J Ethnopharmacol. 2017;206:274-282.
[21] JOOSTEN LA, ABDOLLAHI-ROODSAZ S, DINARELLO CA, et al. Toll like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016;12(6):344-357.
[22] CRISAN TO, CLEOPHAS MC, OOSTING M, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis. 2016;75(4):755-762.
[23] FATTORI V, ZARPELON AC, STAURENGO-FERRARI L, et al. Budlein A, a sesquiterpene lactone from viguiera robusta, alleviates pain and inflammation in a model of acute gout arthritis in mice. Front Pharmacol. 2018;9:1076.
[24] GAO W, ZHAO Z, YU G, et al. VEGI attenuates the inflammatory injury and disruption of blood-brain barrier partly by suppressing the TLR4/NF-κB signaling pathway in experimental traumatic brain injury. Brain Res. 2015;1622(24):230 -239.
[25] CUI L, FENG L, ZHANG ZH, et al. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation. Int Immunopharmacol. 2014;23(1):294-303.
[26] KIM C, CHO SK, KIM KD, et al. β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NF-κB-regulated gene products. Apoptosis. 2014;19(4):708-718.
[27] JIANG X, ANDJELKOVIC AV, ZHU L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol. 2018;163-164: 144-171.
[28] LU Y, ZHANG XS, ZHANG ZH, et al. Peroxiredoxin 2 activates microglia by interacting with Toll-like receptor 4 after subarachnoid hemorrhage.J Neuroinflammation. 2018;15(1):87.
[29] 茅磊, 王汉东. 基质金属蛋白酶MMP-2、MMP-9在中枢神经系统中的作用[J]. 医学研究生学报,2009,22(9):992-995.
[30] OKADA T, LEI L, NISHIKAWA H, et al. TAK-242, Toll-Like Receptor 4 Antagonist, Attenuates Brain Edema in Subarachnoid Hemorrhage Mice. Acta Neurochir Suppl. 2020;127:77-81.
[31] OKADA T, SUZUKI H. Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurismal subarachnoid hemorrhage. Neural Regen Res. 2017;12(2):193-196.
[32] EGASHIRA Y, ZHAO H, HUA Y, et al. White Matter Injury After Subarachnoid Hemorrhage: Role of Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9. Stroke. 2015;46(10):2909-2915.
[33] OKADA T, KAWAKITA F, NISHIKAWA H, et al. Selective Toll-like receptor 4 antagonists prevent acute blood-brain barrier disruption after subarachnoid hemorrhage in mice. Mol Neurobiol. 2019;56(2):976-985.